ATE531822T1 - Diagnose von prostatakrebs - Google Patents
Diagnose von prostatakrebsInfo
- Publication number
- ATE531822T1 ATE531822T1 AT08701643T AT08701643T ATE531822T1 AT E531822 T1 ATE531822 T1 AT E531822T1 AT 08701643 T AT08701643 T AT 08701643T AT 08701643 T AT08701643 T AT 08701643T AT E531822 T1 ATE531822 T1 AT E531822T1
- Authority
- AT
- Austria
- Prior art keywords
- prostate cancer
- kiaa0153
- diagnosis
- biological sample
- inhibiting
- Prior art date
Links
Classifications
-
- G01N33/57555—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/9015—Ligases (6)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88183007P | 2007-01-23 | 2007-01-23 | |
| PCT/EP2008/050761 WO2008090177A2 (en) | 2007-01-23 | 2008-01-23 | Diagnosis of prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE531822T1 true ATE531822T1 (de) | 2011-11-15 |
Family
ID=39512588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08701643T ATE531822T1 (de) | 2007-01-23 | 2008-01-23 | Diagnose von prostatakrebs |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110165178A1 (de) |
| EP (1) | EP2126136B1 (de) |
| AT (1) | ATE531822T1 (de) |
| CA (1) | CA2676436A1 (de) |
| WO (1) | WO2008090177A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| CN103460042B (zh) * | 2011-01-21 | 2015-12-02 | 巴斯利尔药物股份公司 | Glu-微管蛋白作为对呋咱并苯并咪唑类的药物反应的生物标志物的用途 |
| FR3016638B1 (fr) * | 2014-01-23 | 2018-04-13 | Centre National De La Recherche Scientifique - Cnrs - | Nouvelle methode de depistage du cancer de la prostate |
| WO2020243579A1 (en) | 2019-05-30 | 2020-12-03 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
| WO2021252747A1 (en) * | 2020-06-10 | 2021-12-16 | 1Ox Genomics, Inc. | Fluid delivery methods |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6974667B2 (en) * | 2000-06-14 | 2005-12-13 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
-
2008
- 2008-01-23 EP EP08701643A patent/EP2126136B1/de not_active Not-in-force
- 2008-01-23 AT AT08701643T patent/ATE531822T1/de active
- 2008-01-23 US US12/524,112 patent/US20110165178A1/en not_active Abandoned
- 2008-01-23 CA CA002676436A patent/CA2676436A1/en not_active Abandoned
- 2008-01-23 WO PCT/EP2008/050761 patent/WO2008090177A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008090177A3 (en) | 2008-09-18 |
| WO2008090177A2 (en) | 2008-07-31 |
| EP2126136A2 (de) | 2009-12-02 |
| EP2126136B1 (de) | 2011-11-02 |
| CA2676436A1 (en) | 2008-07-31 |
| US20110165178A1 (en) | 2011-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005084109A3 (en) | Cancer specific gene mh15 | |
| ATE554389T1 (de) | Apex als marker für lungenkrebs | |
| WO2007114986A3 (en) | Cooperative probes and methods of using them | |
| ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| GB2451042A (en) | Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds and other chemicals | |
| ES2530843T3 (es) | Métodos basados en microARN para el diagnóstico de cáncer de páncreas | |
| EP2516681A4 (de) | Zusammensetzungen und verfahren zur erkennung kleiner rnas | |
| GB2459228A (en) | Exosome-associated microrna as a diagnostic marker | |
| EA201370063A1 (ru) | Фосфолипидом рака | |
| EA200970891A1 (ru) | Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы | |
| PH12018550037A1 (en) | Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| ATE514755T1 (de) | Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung | |
| WO2012024255A3 (en) | Camkk-beta as a target for treating cancer | |
| WO2009090553A3 (en) | Compositions and methods of detecting post-stop peptides | |
| EP2522743A3 (de) | Zum Prostatakrebsrisiko beitragende genetische Varianten | |
| EA201390638A8 (ru) | Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения | |
| ATE492651T1 (de) | Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs | |
| MX2013000502A (es) | Metodos y kits para el diagnostico de cancer de prostata. | |
| EA200801046A1 (ru) | Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro | |
| WO2008128043A3 (en) | Diagnostic and prognostic methods for renal cell carcinoma | |
| MD20130098A2 (ro) | Test pentru determinarea lizil oxidazei-2 şi metode de utilizare a acestuia | |
| WO2007146668A3 (en) | Use of imp3 as a prognostic marker for cancer | |
| ATE531822T1 (de) | Diagnose von prostatakrebs | |
| ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs |